Skip to main content
. 2022 Jan 24;29(5):3206–3214. doi: 10.1245/s10434-022-11326-5

Table 2.

Pathologic features (n = 524)

n (%)
Final pathology
 MD-IPMN 98 (18.7)
 MT-IPMN 360 (68.7)
 BD-IPMN 66 (12.6)
Invasive IPMN 211 (40.3)
Non-invasive IPMN 313 (59.7)
 LGD 173 (55.3)
 HGD 140 (44.7)

IPMN intraductal papillary mucinous neoplasm, MD-IPMN main-duct IPMN, MT-IPMN mixed-type IPMN, BD-IPMN branch-duct IPMN, LGD low-grade dysplasia, HGD high-grade dysplasia